Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)
Cogent Biosciences' (COGT) quarterly Change in Receivables came in at -$2.0 million in Q1 2020, down 637.63% year-on-year from $372000.0 in Q2 2019, and down 278.57% on a QoQ basis from $1.1 million in Q4 2019.
Cogent Biosciences (COGT) Change in Receivables (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 4 years of Change in Receivables data on file, last reported at -$2.0 million in Q1 2020.
- On a quarterly basis, Change in Receivables fell 637.63% year-over-year to -$2.0 million in Q1 2020; TTM through Dec 2020 was -$2.0 million, a 702.41% decrease from a year earlier, with the FY2020 full-year figure at -$2.0 million, down 702.41% from the prior year.
- Change in Receivables for Q1 2020 stood at -$2.0 million, down from $1.1 million in the prior quarter.
- Over the last five years, Change in Receivables for COGT reached as high as $1.1 million in Q4 2019 and fell as low as -$2.0 million in Q1 2020.
- Historically, Change in Receivables has averaged -$71384.6 across 4 years, with a median of $217000.0 in 2018.
- Across the five-year window, Change in Receivables jumped 1980.49% in 2018 and plunged 637.63% in 2020, its largest moves.
- Year by year, Change in Receivables stood at -$681000.0 in 2017, then jumped by 136.56% to $249000.0 in 2018, then jumped by 349.8% to $1.1 million in 2019, then slumped by 278.57% to -$2.0 million in 2020.
- Per Business Quant data, the three most recent Change in Receivables figures were -$2.0 million in Q1 2020, $1.1 million in Q4 2019, and -$612000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -2.00 Mn |
| Mar 31, 2020 | -2.00 Mn |
| Dec 31, 2019 | 1.12 Mn |
| Dec 31, 2019 | 1.12 Mn |
| Sep 30, 2019 | -612,000.00 |
| Sep 30, 2019 | -612,000.00 |
| Jun 30, 2019 | -548,000.00 |
| Jun 30, 2019 | -548,000.00 |
| Mar 31, 2019 | 372,000.00 |
| Mar 31, 2019 | 372,000.00 |
| Dec 31, 2018 | 249,000.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 217,000.00 |
| Sep 30, 2018 | 217,000.00 |
| Jun 30, 2018 | -399,000.00 |
| Jun 30, 2018 | -399,000.00 |
| Mar 31, 2018 | 771,000.00 |
| Mar 31, 2018 | 771,000.00 |
| Dec 31, 2017 | -681,000.00 |
| Dec 31, 2017 | -681,000.00 |